White Biotechnology Market Report 2026

The white biotechnology market size has grown rapidly in recent years. It will grow from $467.52 billion in 2025 to $517.44 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to rising environmental regulations on chemical manufacturing, availability of fermentation-based production methods, increasing industrial enzyme adoption, expansion of biofuel blending mandates, growth in sustainable manufacturing initiatives.

The white biotechnology market size is expected to see rapid growth in the next few years. It will grow to $763.23 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to increasing investments in green industrial biotechnology, rising demand for bio-based alternatives to petrochemicals, expansion of circular bioeconomy models, growing focus on carbon-neutral production, increasing commercialization of advanced bioprocesses. Major trends in the forecast period include increasing adoption of bio-based industrial processes, rising demand for renewable feedstock utilization, growing use of enzyme-based manufacturing, expansion of bioplastics and biofuels production, enhanced focus on low-emission industrial solutions.

The increasing preference for sustainable products is expected to drive the growth of the white biotechnology market in the coming years. Sustainable products are designed to minimize negative environmental and social impacts, use resources efficiently and responsibly, and remain profitable throughout their life cycle. White biotechnology enables the development of sustainable products by employing microorganisms, enzymes, and biocatalysts to create eco-friendly and resource-efficient products and processes across various industries. For example, in July 2024, according to the Energy Information Administration, a US-based government agency, the production capacity of sustainable aviation fuel (SAF) in the United States is projected to increase from approximately 2,000 barrels per day (b/d) to nearly 30,000 b/d by 2024. Therefore, the growing preference for sustainable solutions is fueling growth in the white biotechnology market.

Key companies in the white biotechnology market are adopting technological innovations such as advanced biopolymer and co-polymer platforms to develop sustainable, customized products for diverse applications. Advanced biopolymer and co-polymer platforms are biotechnological systems that allow scientists to design and optimize polymers at the molecular level, creating high-performance, sustainable materials that can replace petroleum-based polymers while meeting evolving market and regulatory demands. For instance, in June 2023, International Flavors & Fragrances Inc., a US-based manufacturer of fragrances, flavors, and cosmetic actives, launched Designed Enzymatic Biomaterials (DEB) technology, a biomaterials platform designed to deliver sustainable biopolymers. The DEB platform enables producers to adapt to changing market and regulatory requirements by substituting conventional synthetic polymers derived from fossil fuels. Through this technology, scientists can directly replicate the properties of petroleum-based polymers in biopolymer materials, customizing polysaccharides to achieve long-term performance improvements in targeted applications.

In February 2025, Sensient Technologies Corporation, a US-based specialty ingredients company, acquired Biolie SAS for an undisclosed amount. Through this acquisition, Sensient aims to expand its active-color and natural ingredient portfolio, strengthening its sustainable cosmetics and personal-care offerings. Biolie SAS, a France-based biotechnology company, specializes in white biotechnology, utilizing patented enzymatic, solvent-free extraction methods to produce natural plant-derived oils, pigments, and functional botanical extracts for the cosmetic and nutrition-health markets.

Major companies operating in the white biotechnology market are Novozyme A/S., Koninklijke DSM N.V., BASF SE., Du Pont Danisco., Amyris Inc., Henkel AG & Co. KGaA., Kaneka Corporation., Evonik Industries AG., Evolva Holding., EUCODIS Bioscience GmbH., Lonza Group Ltd., Borregaard ASA., Codexis Inc., Deinove SA., Fermentalg SA., Gevo Inc., Global Bioenergies SA., Metabolic Explorer SA.

North America was the largest region in the white biotechnology market in 2025. The regions covered in the white biotechnology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the white biotechnology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the white biotechnology market by increasing costs of imported fermentation equipment, bioreactors, enzymes, and specialty raw materials used in biofuel, biochemical, and biomaterial production. Europe and North America are most affected due to reliance on imported processing equipment, while Asia-Pacific faces cost pressures on export-oriented bioproduct manufacturing. These tariffs are raising capital costs and slowing plant expansion projects. However, they are also encouraging domestic biomanufacturing, regional enzyme production, and localized sourcing of renewable feedstocks.

The white biotechnology market research report is one of a series of new reports that provides white biotechnology market statistics, including white biotechnology industry global market size, regional shares, competitors with a white biotechnology market share, detailed white biotechnology market segments, market trends and opportunities, and any further data you may need to thrive in the white biotechnology industry. This white biotechnology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

White biotechnology refers to a branch of biotechnology focused on industrial production, providing essential components for the food, pharmaceutical, agricultural, and other industries. Also known as environmental biotechnology, it involves the environmentally friendly synthesis of biochemicals, biomaterials, and biofuels from renewable resources using living cells and/or their enzymes. White biotechnology leverages biological processes to produce various industrial products.

The primary product types of white biotechnology are biofuels, biomaterials, biochemicals, and industrial enzymes. Biofuels are renewable energy sources, including biodiesel, biogas, and ethanol, produced by living organisms. Biotechnologically produced biofuels function more like conventional gasoline, offering improved fuel efficiency and fewer blending issues than ethanol. White biotechnology products are applied in bioenergy production, food and feed additives, pharmaceutical ingredients, personal care and household products, and other applications.

The white biotechnology market includes revenues earned by entities by providing enzyme engineering, synthetic biology, metabolic engineering, fermentation, separation and purification processes. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.